A new peer-reviewed clinical study has unveiled game-changing results in the field of medical weight loss, thanks to Ivim Health’s IVIM (Individualized Virtual Integrative Medicine) protocol. Patients using the protocol in combination with GLP-1 therapies, like semaglutide, achieved nearly 50% greater weight loss than traditional methods.
Why It Matters
Weight loss isn’t just about prescriptions anymore. Ivim Health’s approach offers a complete care ecosystem — combining expert guidance, functional coaching, app-based tracking, and community support — all delivered virtually.
Key Findings from the Study
- Average 52-week weight loss: 45.9 lbs (19.5%)
- 68-week results: 46.9 lbs (21.8%)
- Nearly half of participants lost more than 20% of their body weight
- Over 99% lost at least 5%
- Low adverse event rate: only 1.7%
- Equal success across branded and compounded GLP-1 therapies
Beyond the Prescription
“This isn’t just about writing a prescription, it’s about rewriting the patient experience,” said Dr. Taylor Kantor, Chief Medical Officer and co-founder of Ivim Health. “We don’t write prescriptions and send patients on their way. From day one, we partner with our patients—delivering compassionate care, ongoing guidance, and surrounding them with a team that actually listens. Our outcomes speak for themselves, but our mission goes even deeper: to restore what healthcare was always meant to be – compassionate, continuous, and centered on each individual’s unique journey.”
Real-Life Transformation
“I’ve lost 100 pounds and regained my health,” shares patient Lindsay Patterson. “It wasn’t just the meds—it was the system, the people, the support.”
Share your Details for subscribe